An interventional study of neuromuscular stimulation and mindfulness and neuromuscular electrical stimulation in Stroke, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 50 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-03-13.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 41 studies in Stroke by Cairo University — 20 open to participants now, 22 under way, none of them phase 3. Stroke · Cairo University.
Among the 41 studies in Stroke by Cairo University, this one is the 8th largest by planned enrollment of the 38 interventional ones that give a count, is one of 12 that started in 2026, is one of 38 with no phase, reaches primary completion later than 18 of the 21 other live ones, and was the 11th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →20 of the 41 studies in Stroke by Cairo University are open now, in 1 country. Recruiting first, the newest first:
Cairo University · Sites in Egypt
Ages 40 wk–60 wk · Healthy volunteers
Cairo University · Sites in Egypt
Ages 50–60
Cairo University · Sites in Egypt
Ages 49–65
Cairo University · Sites in Egypt
Ages 40–55
Cairo University · Sites in Egypt
Ages 55–65
By country, each count listing its studies:
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 50 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
41 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 12 started in 2026.
This study's planned enrollment of 60 is above the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 40 across the 38 interventional studies, 68 across the 3 observational. Of the 19 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Cairo University is the lead sponsor of 4,967 studies on the registry; 1,474 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
5 of the studies in Stroke by Cairo University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07520253Cairo UniversityEffect of Virtual Reality on Cortical Reorganization and Upper Extremity Functional Recovery in Patients With Subacute Stroke | 2026-11-30 |
| NCT07727902Cairo UniversityFunctional Inspiratory Muscle Training for Gait Recovery in Patients With Chronic Stroke | 2026-12-01 |
| NCT06302946Cairo UniversityEffect of Neuromuscular Stimulation and Mindfulness Exercise in Patients With Stroke | 2026-12-01 |
| NCT07626242Cairo UniversityEffect of Non-invasive Vagus Nerve Stimulation on Cerebrovascular Reactivity and Cognition in Chronic Stroke Patients | 2027-02-15 |
| NCT07947433Cairo UniversityEffect of taVNS on Post-stroke Dysphagia | 2027-03 |
Add all 5 to your calendar (.ics) → With an account.
Among the 41 studies in Stroke by Cairo University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
It is an interventional study in which 60 stroke patients were estimated to enroll according to random allocation and divided into two groups. The experimental group will receive neuromuscular stimulation and mindfulness , while the control group will receive neuromuscular stimulation only.
It is an interventional study in which 60 stroke patients will be estimated to enroll according to random allocation and divided into two groups. The experimental group will receive neuromuscular stimulation and mindfulness, while the control group will receive neuromuscular stimulation only. The experimental group participants will receive neuromuscular electrical stimulation that will last 12 consecutive weeks, three sessions per week protocol with Mindfulness.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The potential participants will be excluded if they meet one of the following criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
will receive neuromuscular stimulation and mindfulness
Other: neuromuscular stimulation and mindfulness
The control group will receive neuromuscular stimulation only.
Other: neuromuscular electrical stimulation
Receive neuromuscular stimulation and mindfulness breathing; the experimental group participants will receive neuromuscular electrical stimulation with Mindfulness.
participants in the control group perceived neuromuscular electrical stimulation
ventilatory function
By a spirometer, forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), the ratio of forced vital capacity to forced expiratory volume (FEV1/FVC), and peak expiratory flow will be measured.
Time frame: 12 weeks
level of stress
perceived stress questionnaire Individual scores on the perceived stress questionnaire can range from 0 to 40 with higher scores indicating higher perceived tress
Time frame: 12 weeks
Functional independence measure
The Functional independence measure consists of 18 measures organized into six dimensions and ranges from 18 to 126
Time frame: 12 weeks
level of physical function
short physical performance battery group of measures that combines the results of the gait speed, chair stand and balance tests
Time frame: 12 weeks
Plan to share: Yes — sharing with other researches
Supporting information: Study protocol
Time frame: 12 months
Access criteria: after acceptance of publishing journal
Data sharing details ↗ · www.ekb.com
No publications or documents are linked to this record.
Start is estimated for Mar 2026; primary completion for Dec 2026, 8 months later.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 8 months is below that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.